Table: begin end state 1 25 signal peptide 26 27 non-cytoplasmic 28 38 transmembrane 39 47 non-cytoplasmic 48 53 cytoplasmic 54 73 transmembrane 74 75 cytoplasmic 76 95 non-cytoplasmic 96 117 transmembrane 118 137 cytoplasmic 138 164 transmembrane 165 170 non-cytoplasmic 171 196 transmembrane 197 216 cytoplasmic 217 236 transmembrane 237 241 non-cytoplasmic 242 259 transmembrane 260 278 cytoplasmic 279 299 transmembrane 300 314 non-cytoplasmic 315 353 transmembrane 354 356 cytoplasmic 357 358 non-cytoplasmic 359 384 transmembrane 385 403 non-cytoplasmic 404 429 transmembrane 430 430 cytoplasmic
Input: >WP_004303790.1 NCBI__GCF_000310185.1:WP_004303790.1 MTVGLLSLLAVLVLAFLRVPLAFALLSVSLGGIGVVMGWDVARSLVPMTISEAVFSYELA VVPMFILMGNILARTGISDDLFRAANAFLGPVRGGLALSTMVTCAGFSAVCGSSLATAAT MSKVAYPSMKRYGYSDALASATIAAGGTLGILIPPSIILMIYGILTQTNIGHLFVAGVVP GLLGLLMYLLVIYAVARISPQDAPRGERTTMAEKLHALRGVWPFTLLFVLIIGGLYGKLF TATEAAGMGAGLALILSMVQGRMSWQDFRHIFIETATTSVMLYSVLFGALLFAKLISFSG LGEGILELFNQAGLGPWGTIVAILVVFLLLGCVMDSLAIILICVPLFVPILLAHGFDLVW FGIIVVVVTEIALITPPIGMNVFVLKATLPHVRLGAIFRGLTPFIAIDLVRLALLVIFPS ISLALVAFMK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server